Sep 30, 2018

United Therapeutics Q3 2018 Earnings Report

Total Revenue
$413M
Previous year: $446M
-7.4%
EPS
$3.98
Previous year: $4.69
-15.1%
Gross Profit
$361M
Previous year: $426M
-15.3%
Cash and Equivalents
$656M
Previous year: $1.07B
-38.5%
Free Cash Flow
$163M
Previous year: $237M
-31.1%
Total Assets
$3.41B
Previous year: $2.94B
+16.2%

United Therapeutics

United Therapeutics